{
    "SPADE_UN_30500": {
        "Sequence Information": {
            "Peptide Name": "Tritrpticin PST13-RK, K-Tritrpticin [V1,L11Del][R1,2,12,13K]-K",
            "Sequence": "KKKFPWWWPFKKK",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P51524",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P51524",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity.",
                    "Pubmed ID": "18815734",
                    "Reference": "Biotechnol Lett. 2009;31:233-237",
                    "Author": "Yang ST, Kim JI, Shin SY",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/18815734"
                },
                {
                    "Title": "Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities.",
                    "Pubmed ID": "16563706",
                    "Reference": "Int J Antimicrob Agents. 2006;27:325-330",
                    "Author": "Yang ST, Shin SY, Hahm KS, Kim JI",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/16563706"
                }
            ],
            "Mass": 1834.26,
            "PI": 10.7,
            "Net Charge": 6,
            "Hydrophobicity": -1.82,
            "Frequent Amino Acids": "KWF",
            "Absent Amino Acids": "ACDEGHILMNOQRSTUVY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 2,
            "Polar Residues": 11,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_30500",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00036",
                    "Similarity": 1.0,
                    "Sequence": "KKKSGVIPTVSHDCHMNTFQFMFTCCS"
                },
                {
                    "SPADE_ID": "SPADE_N_00037",
                    "Similarity": 1.0,
                    "Sequence": "KKKSGVIPTVSHDCHMNSFQFVFTCCS"
                },
                {
                    "SPADE_ID": "SPADE_N_04922",
                    "Similarity": 1.0,
                    "Sequence": "KKKRRSREK"
                }
            ],
            "Hemolytic Activity": "Mouse fibroblasts NIH 3T3:IC50=83 µg/ml,Human erythrocytes:50% Hemolysis=>200 µM",
            "Target Organism": "Escherichia coli KCTC 1682(MIC=8µg/ml),Salmonella typhimurium KCTC 1926(MIC=2µg/ml),Pseudomonas aeruginosa KCTC 1637(MIC=8µg/ml),Proteus vulgaris KCTC 2433(MIC=8µg/ml),Bacillus subtilis KCTC 1918(MIC=2µg/ml),Streptococcus pyogenes KCTC 3096(MIC=8µg/ml),Staphylococcus aureus KCTC 1621(MIC=4µg/ml),Staphylococcus epidermidis KCTC 1917(MIC=2µg/ml),Human lung carcinoma A549(IC50=90µg/ml),Human breast adenocarcinoma MDA-MB-361(IC50=80µg/ml)"
        }
    }
}